The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vasil'eva M.P.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Rudenko T.E.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Kutyrina I.M.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Solomakhina N.I.

Ministry of Health of Russia, Moscow, Russia ,Hospital Therapy Department One, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease

Authors:

Vasil'eva M.P., Rudenko T.E., Kutyrina I.M., Solomakhina N.I.

More about the authors

Journal: Therapeutic Archive. 2015;87(6): 17‑22

Views: 6493

Downloaded: 591


To cite this article:

Vasil'eva MP, Rudenko TE, Kutyrina IM, Solomakhina NI. Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease. Therapeutic Archive. 2015;87(6):17‑22. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.